Celltex Offers Stem Cell Holiday Banking Gift Certificate

Twenty percent off regular-priced banking fee Celltex is offering existing clients the opportunity to provide a gift of a lifetime to your family members this holiday season: a holiday banking gift certificate. This gift, deemed invaluable by many, provides family members with the security that their own mesenchymal stem cells will be safely banked for future therapeutic use. The banking package, priced at $5,200, is a timeless gift with no expiration date that includes a banking agreement for 20 percent … read more


$1.04 million grant from U.S. Army

Lipin Tang, a UT Arlington bioengineering professor aims to regenerate cartilage tissue and reduce osteoarthritis using a patient’s own stem cells (the same types of cells that Celltex uses in our technology) through the injection of microscaffolding. Tang, who is using a $1.04 million grant from the United States Army is focusing his research primarily on soldiers who were severely injured in battle and who now suffer from Posttraumatic Osteoarthritis. Posttraumatic Osteoarthritis often occurs in soldiers who suffered broken bones … read more


City scientists’ stem cell research could be boon for diabetics

The medical benefits of mesenchymal stem cells (MSCs), the same type of cells used by Celltex in our proprietary isolation and banking technology, are far-reaching. Researchers in Vadodara, India have conducted a study using MSCs that may be helpful for those using insulin to treat diabetes. Dr. Rajini Vyas and her team began the study in 2006 and focused on MSCs. Through the process of differentiation, Islet-like Cell Aggregates (ICA), which are clusters of cells that produce hormones, are created … read more


Celltex announces ‘joint’ partnership with Arthritis Foundation South Central Region

Houston-based biotechnology company Celltex Therapeutics Corporation is proud to announce a partnership with the Arthritis Foundation South Central Region. The coming together of these organizations marks a milestone for the future of regenerative medicine for people who are living with arthritis. Founded in 2011 by David Eller and internationally-known spine surgeon, Dr. Stanley Jones, Celltex has been generating breakthroughs in the autologous (ones own) stem cell field to improve the quality of life for those suffering from injuries or vascular, … read more


Stem Cell Treatment: Out from the Shadows, Onto the Cutting Edge

MMQB.com released an intensive look into the number of professional athletes who are turning to adult mesenchymal stem cells (the kind that we all have in our own body and the same kind used by Celltex) to help them recover from sports-related injuries. According to the article published in late July, stem cell therapy is the next big breakthrough in sports medicine. Still, restrictions for use in the U.S. make stem cells an important and debated topic in regenerative medicine … read more


Celltex Supports Arthritis Foundation in Annual Joints in Action Golf Tournament

Celltex Therapeutics Corporation (Celltex) helped sponsor the Ninth Annual Joints in Action Golf Tournament, which invites golf enthusiasts to play a round for a good cause. The Tournament, founded by Dr. Bill Bryan and co-chaired by James Dumler and Lee Hollmann, took place on Thursday, August 28th at the Kingwood Country Club in Kingwood, TX, and honored Dr. Stanley Jones, chief medical officer at Celltex, as this year’s medical honoree. The annual charity event, which raises more than $200,000 every … read more


Celltex joins national basketball retired players association at 2014 Legends World Sports Conference

Houston-based biotechnology company Celltex Therapeutics Corporation took part in the National Basketball Retired Players Association (NBRPA) 2014 Legends World Sports Conference in Cancun, Mexico on August 22-24, 2014 sharing the potential of stem cell use in regenerative therapy for athletes. The annual conference attracted nearly 100 retired players from the NBA, ABA, WNBA and Harlem Globetrotters to network, participate in various workshops and unite in community service. Celltex, formed in 2011 by David G. Eller and internationally-known surgeon Dr. Stanley … read more


Promising results for stem-cell pain study

Researchers in Sydney, Australia have seen promising results in a study using Mesenchymal Stem Cells to treat neuropathic pain in female patients. Mesenchymal Stem Cells are the same type of cells used by Celltex in our exclusive technology. Click here to read more about the Australian trial results.